Mengis Capital Management, Inc. Astrazeneca PLC Transaction History
Mengis Capital Management, Inc.
- $456 Million
- Q2 2025
A detailed history of Mengis Capital Management, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Mengis Capital Management, Inc. holds 72,860 shares of AZN stock, worth $5.39 Million. This represents 1.12% of its overall portfolio holdings.
Number of Shares
72,860
Previous 60,710
20.01%
Holding current value
$5.39 Million
Previous $4.46 Million
14.1%
% of portfolio
1.12%
Previous 0.96%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,425Shares Held
505MCall Options Held
9.82MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.22 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$3.01 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.64 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.36 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.31 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $229B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...